Adaptive Response of Beta-Adrenergic Sensitive Adenylate Cyclase System

  • V. Homburger
  • R. Bouhelal
  • C. Pantaloni
  • J. Bockaert
Conference paper
Part of the NATO ASI Series book series (volume 6)

Abstract

In the beta adrenergic adenylate cyclase system, persistent stimulation of the cells by catecholamines or analogs results in a decline of the cyclic AMP response. This phenomenon generally referred to as desensi-tization has been classified in two types by Perkins and coworkers (1). In the first one called heterologous, incubation with one agonist leads to an attenuated response to different multiple hormones operating via distinct receptors. In the second one referred to as homologous or agonist-specific, only the subsequent response to the desensitizing hormone is diminished while the efficiency of other hormones is unimpaired. This type of desensi-tization, characterized by a decrease in adenylate cyclase stimulation by beta-adrenergic agonists, is associated in most cases with a loss or disappearance of beta-adrenergic receptors (for reviews see 2,3,4): this phenomenon is called down-regulation. The down-regulated receptors can be recycled to the cell surface or destroyed within the cell (2,3,4).

Keywords

Lymphoma Estrogen Mold Sedimentation Adenosine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Su, Y.F., Cubeddu-Ximenez, L., and J.P. Perkins: Regulation of adenosine 3′-5′ monophosphate content of human astrocytoma cells: desensitization to catecholamines and prostaglandins. J. Cyclic Nucleotide Res. 2: 257–270 (1976)PubMedGoogle Scholar
  2. 2.
    Harden, T.K.,: Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol. Reviews 35: 5–32 (1983)Google Scholar
  3. 3.
    Sibley, D.R. and R.J. Lefkowitz: Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor coupled adenylate cyclase system as a model. Nature 317: 124–129 (1985)PubMedCrossRefGoogle Scholar
  4. 4.
    Hertel, C. and J.P. Perkins: Receptor-specific mechanisms of desensitization of beta-adrenergic receptor function. Mol. Cell. Endocrinol. 37: 245–256 (1984)PubMedCrossRefGoogle Scholar
  5. 5.
    Hughes, R.J. and P. Insel: Agonist-mediated regulation of alpha1 and beta2 adrenergic receptor metabolism in a muscle cell line, BC3H1. Mol. Pharmacol. 29: 521–530 (1986)PubMedGoogle Scholar
  6. 6.
    Morishima, I., Thompson, W.J., Robison, G.A. and S.J. Strada: Loss and restoration of sensitivity to epinephrine in cultured BHK cells: effect of inhibitors of RNA and protein synthesis. Mol. Pharmacol. 18: 370–378 (1980)PubMedGoogle Scholar
  7. 7.
    Shear, M., Insel, P.A., Melmon, K.L. and P. Coffino: Agonist-specific refractoriness induced by isoproterenol. J. Biol. Chem. 251: 7572–7576 (1976)PubMedGoogle Scholar
  8. 8.
    De Vellis J. and G. Brooker: Reversal of catecholamine refractoriness by inhibitors of RNA and protein synthesis. Science 186: 1221–1223 (1974)CrossRefGoogle Scholar
  9. 9.
    Homburger, V. Lucas, M., Cantau, B., Barabe, J., Penit, J. and J. Bockaert: Further evidence that desensitization of beta-adrenergic sensitive adenylate cyclase proceeds in two steps. J. Biol. Chem. 255: 10436–10444 (1980)PubMedGoogle Scholar
  10. 10.
    Fishman, P., Mallorga, P. and J.F. Tallman: Catecholamine-induced desensitization of adenylate cyclase in rat C6 glioma cells; Evidence for a specific uncoupling of beta-adrenergic receptors from a functional regulatory component of adenylate cyclase. Mol. Pharmacol. 20: 310–318 (1981)PubMedGoogle Scholar
  11. 11.
    Frederich, Jr, R.C., Waldo, G.L., Harden, J.K. and J.P. Perkins: Characterization of agonist-induced beta-adrenergic receptor-specific desensitization in C62B glioma cells. J. Cyclic Nucleotide Res. 9: 103–118 (1983)Google Scholar
  12. 12.
    Steinman, R.M., Mellman, I.S., Muller, W.A., and Z.A. Cohn: Endocytosis and the recycling of plasma membrane. J. Cell. Biol. 96: 1–27 (1983)PubMedCrossRefGoogle Scholar
  13. 13.
    Homburger, V., Gozlan, H., Bouhelal, R., Lucas, M., and J. Bockaert: Irreversible blockade of beta-adrenergic receptors with a bromoacetyl derivative of pindolol. Naunyn-Schmiedeberg’s Arch. Pharmacol. 328: 279–287 (1985)CrossRefGoogle Scholar
  14. 14.
    Homburger, V., Pantaloni, C., Lucas, M., Gozlan H., and J. Bockaert. Beta-adrenergic receptor repopulation of C. glioma cells after irreversible blockade and down regulation. J. Cell. Physiol. 121: 589–597 (1984)PubMedCrossRefGoogle Scholar
  15. 15.
    Bouhelal, R., Guillon, G., Homburger, V., and J. Bockaert: Forskolin-induced change of the size of adenylate cyclase. J. Biol. Chem. 260: 10901–10904 (1985)PubMedGoogle Scholar
  16. 16.
    Martin, R.G., and B.M. Ames: A method for determining the sedimentation behavior of enzymes: application to protein mistures. J. Biol. Chem. 236: 1372–1379 (1961)PubMedGoogle Scholar
  17. 17.
    Sholl, S., and M.E. Lippman: The estrogen receptor in MCF- 7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor. Endocrinology 115: 1295–1301 (1984)CrossRefGoogle Scholar
  18. 18.
    Chuang, D.M., and E. Costa: Evidence for internalization of the recognition site of beta-adrenergic receptors during receptor subsen-sitivity induced by (-) isoproterenol. Proc. Natl. Acad. Sci. USA 76: 3024–3028 (1979)PubMedCrossRefGoogle Scholar
  19. 19.
    Harden, T.K., Cotton, C.U., Waldo, G.L., Lutton, J.K., and J.P. Perkins: Catecholamine-induced alteration in the sedimentation behavior of membrane bound beta adrenergic receptors. Science 210: 441–443 (1980)PubMedCrossRefGoogle Scholar
  20. 20.
    Hertel, C., Staehelin, M., and J.P. Perkins: Evidence for intravesicular beta-adrenergic receptors in membrane fractions from desensitized cells; binding of the hydrophilic ligand CGP-12177 only in the presence of alamethicin. J. Cyclic Nucleotide Res. 9: 119–128 (1983)Google Scholar
  21. 21.
    Toews, M.L., Harden, T.K., and J.P. Perkins. High affinity binding of agonists to beta-adrenergic receptors on intact cells. Proc. Natl. Acad. Sci. USA 80: 3553–3557 (1983)PubMedCrossRefGoogle Scholar
  22. 22.
    Doss, R.C., Perkins, J.P., and Harden, T.K.: Recovery of beta-adrenergic receptors following long term exposure of astrocytoma cells to catecholamines. J. Biol. Chem. 256: 12281–12286 (1981)PubMedGoogle Scholar
  23. 23.
    Brown, M.S., Anderson, R.G.W., and J.L. Goldstein: Recycling receptors: the round-trip itinerary of migrant membrane protein. Cell 32: 663–667 (1983)PubMedCrossRefGoogle Scholar
  24. 24.
    Homburger, V., Lucas, M., Rosenbaum, E., Vassent, G., and J. Bockaert: Presence of both beta1 and beta2 — adrenergic receptors in a single cell type. Mol. Pharmacol. 20: 463–469 (1981)PubMedGoogle Scholar
  25. 25.
    Mauger, J.P., and M. Worcel: Relationship between the (-) (3H)-DHA binding to beta adrenoceptors and transmembrane Rb efflux of the BC3H-1 non fusing muscle cell line. Br. J. Pharmacol. 68: 731–739 (1980)PubMedGoogle Scholar
  26. 26.
    Hughes, R.J., Boyle, M.R., Brown, R.D., Taylor, P., and P.A. Insel: Characterization of coexisting alpha1 and beta2 adrenergic receptors on a cloned muscle cell line, BC3H-1. Mol: Pharmacol. 22: 258–266 (1982)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • V. Homburger
    • 1
  • R. Bouhelal
    • 1
  • C. Pantaloni
    • 1
  • J. Bockaert
    • 1
  1. 1.Centre CNRS-INSERM de Pharmacologie-EndocrinologieMontpellier CedexFrance

Personalised recommendations